Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
---|
12/23/1993 | CA2138392A1 5-(1,2,4-triazol-1-ylmethyl)-3h-isobenzofuran-1-one derivatives, their preparation and use as aromatase inhibitors |
12/23/1993 | CA2138151A1 New polypeptides with a nmda receptor activity, nucleic acid coding for these polypeptides and their use |
12/23/1993 | CA2138146A1 Proteinoid carriers and methods for preparation and use thereof |
12/23/1993 | CA2137834A1 Therapeutic compositions |
12/23/1993 | CA2137819A1 Vinyl arenas having retinoid-like activity |
12/23/1993 | CA2137782A1 Therapeutic triazine compounds and use |
12/23/1993 | CA2137684A1 Novel piperazinyl-bis(alkylamino)-pyrimidine derivatives and process for preparing same |
12/23/1993 | CA2137681A1 Use of fatty acids, e.g.z-hydroxymystic acids, as antiviral agents |
12/23/1993 | CA2137679A1 Use of cyclic depsipeptides having 18 ring atoms for combating endoparasites, new cyclic depsipeptides having 18 ring atoms, and processes for their preparation |
12/23/1993 | CA2137547A1 Chimeric receptor polypeptides, human h13 proteins and uses thereof |
12/23/1993 | CA2137469A1 Veterinary rehydration product |
12/23/1993 | CA2137285A1 Alpha-2-adrenergic agonists for treating presbyopia |
12/23/1993 | CA2136547A1 Novel biologically active eburnamenine derivatives, pharmaceutical compositions containing them and process for preparing same |
12/23/1993 | CA2136546A1 Novel steroids with pregnane skeleton, pharmaceutical compositions containing them and process for preparing same |
12/23/1993 | CA2134222A1 Antihypercholesterolemic compounds and related pharmaceutical compositions and methods of use |
12/23/1993 | CA2117538A1 Process for the preparation of clavulanic acid |
12/23/1993 | CA2114643A1 Derivatives of substituted imidazo benzoxazin-1-one and process for their preparation |
12/23/1993 | CA2112360A1 Bicyclic fibrinogen antagonists |
12/23/1993 | CA2098876A1 2'-deoxy-2',2-'difluoro(2,6,8-substituted)purine nucleosides having anti-viral and anti-cancer activity and intermediates |
12/23/1993 | CA2098875A1 2'-deoxy-2'-2'-difluoro(4-substituted pyrimidine)nucleosides having anti-viral and anti-cancer activity and intermediates |
12/23/1993 | CA2098780A1 Pharmaceutical compositions containing amidines and novel amidines |
12/22/1993 | EP0575210A1 Azole derivatives, pharmaceutical compositions containing the same, and methods for treating mycosis and estrogen-dependent diseases |
12/22/1993 | EP0575137A1 Oral composition containing carrier-bound antimicrobials |
12/22/1993 | EP0575097A1 2,3-Bis-carboxamidomethyl substituted oxiranes as inhibitors of HIV protease and their use for the treatment of AIDS |
12/22/1993 | EP0575069A1 Method for preparing 7-oxabicycloheptyl substituted oxazole amide prostaglandin analog intermediates useful in the preparation of antithrombotic and anti-vasospastic compounds |
12/22/1993 | EP0575048A1 Treatment of neurodegenerative diseases |
12/22/1993 | EP0575020A1 Non-aqueous liquid antibacterial oral composition exhibiting improved uptake on dental tissue surfaces |
12/22/1993 | EP0574906A2 Piperazine and homopiperazine derivatives, pharmaceutical compositions containing them and process for preparing the same |
12/22/1993 | EP0574894A1 Composition of gastric acid - resistant microspheres containing buffered bile acids |
12/22/1993 | EP0574857A1 Compounds 31668P and 31668U, a process for their production and their use |
12/22/1993 | EP0574846A2 Imidazopyridines as angiotensin II antagonistes |
12/22/1993 | EP0574822A1 Pharmaceutical soft capsules containing lysin clonixinate and method to produce them |
12/22/1993 | EP0574808A1 Amidine-biphenyl derivatives, process for their production & medical preparation containing them |
12/22/1993 | EP0574787A2 Benzimidazole derivatives as angiotensin II antagonists |
12/22/1993 | EP0574781A2 2-Amino-5-heterocyclic-substituted-1,4-benzodiazepines and their use in the treatment of aids |
12/22/1993 | EP0574774A1 Substituted benzothiazolyl- and quinoxalyl methoxy-phenyl acetic acid derivatives |
12/22/1993 | EP0574758A1 Hydroxamic acid derivatives as collagenase inhibitors |
12/22/1993 | EP0574726A1 Annelated 1,2,5-oxadiozole-2 oxides and their use as pharmacological agents |
12/22/1993 | EP0574624A1 Pharmaceutical compositions |
12/22/1993 | EP0574579A1 Dna encoding a human 5-ht 1f? receptor and uses thereof |
12/22/1993 | EP0574571A1 Pharmaceutical compositions containing polymer derivative-bound anthracycline glycosides and a method for their preparation |
12/22/1993 | EP0574510A1 Neolignan derivatives as platelet activating factor receptor antagonists and 5-lipoxygenase inhibitors |
12/22/1993 | EP0574504A1 Pharmaceutical preparations for the therapy of tumors containing colchicine as the active principle and methods for the use of the same |
12/22/1993 | EP0574494A1 Indoles useful as platelet activating factor antagonists |
12/22/1993 | EP0574487A1 Use of 5-fluoro-2'-deoxy-3'-thiacytidine for the treatment of hepatitis b |
12/22/1993 | EP0574477A1 Pharmaceuticals |
12/22/1993 | EP0574457A1 Antiviral nucleoside combination |
12/22/1993 | EP0574424A1 Novel salts/ion pairs of non-steroidal anti-inflammatory drugs in various dosage forms |
12/22/1993 | EP0574404A1 Psyllium and cholestyramine compositions with improved palatability |
12/22/1993 | EP0574383A1 Color modified melanins and methods for their preparation and use. |
12/22/1993 | EP0444194B1 Agent for thermotherapy |
12/22/1993 | EP0413016B1 Novel compositions containing hyaluronic acid associates and a process for preparing same |
12/22/1993 | CN1079747A Steroid 5-alpha-reductase inhibitors |
12/22/1993 | CN1079745A New 4-fluoro-7-oxo-H-pyridoi1,2,3-DEÙÛ1,4Ùbenzoxazing-6-carboxyl IC acids and esters |
12/22/1993 | CN1079744A 7-oxo-7H-pyrido Û1,2,3-DEÙÛ1,4Ùbenzoxazine-6-carboxylic acids and esters |
12/22/1993 | CN1079743A Process for the production of clavulanic acid salts |
12/22/1993 | CN1079739A 四氢噻吩衍生物 Tetrahydrothiophene derivative |
12/22/1993 | CN1079738A 杂二环化合物 Heterobicycle compound |
12/22/1993 | CN1079732A Pharmaceutical compounds |
12/22/1993 | CN1079651A Minimizing progestin associated breakthrough bleeding |
12/22/1993 | CN1079650A New use of nicotinic acid and its derivative |
12/22/1993 | CN1079649A Imidazolyl-alkenoic acids |
12/22/1993 | CN1079648A Imidazolyl-alkenoic acids |
12/22/1993 | CN1023229C Stable mixture containing oxidation-sensitive compounds, its prepn. and application |
12/22/1993 | CN1023226C Prepn. method of medical compounds |
12/22/1993 | CN1023219C Substituted imidazole derivatives and their preparation and use |
12/22/1993 | CN1023191C Process for producing sustained release ibuprofen preparation |
12/21/1993 | US5272271 Pyranobenzoxadiazole derivatives |
12/21/1993 | US5272270 Process for the preparation of 1-alkylisoquinoline derivatives |
12/21/1993 | US5272266 Vinylsulphonylpristinamycin and its preparation |
12/21/1993 | US5272263 DNA sequences encoding vascular cell adhesion molecules (VCAMS) |
12/21/1993 | US5272180 Cell proliferation inhibitor |
12/21/1993 | US5272177 Use of sebacic acid and derivatives thereof in enteral and parenteral nutrition and pharmaceutical compositions containing said compounds |
12/21/1993 | US5272176 Advanced glycation inhibitors containing amino-benzoic acids and derivatives, and methods of use |
12/21/1993 | US5272171 Phosphonooxy and carbonate derivatives of taxol |
12/21/1993 | US5272168 Use of 5HT-3 antagonists in preventing or reducing dependency on dependency-inducing agents |
12/21/1993 | US5272166 Method for selective reduction of Lp(a) |
12/21/1993 | US5272165 2-alkylidene-aminoguanidines and methods of use therefor |
12/21/1993 | US5272163 Therapeutic amides |
12/21/1993 | US5272161 Indolesulphonamide-substituted dihydropyridines |
12/21/1993 | US5272158 Fibrinogen receptor antagonists |
12/21/1993 | US5272155 (+)-2-methylpiperidine as modulator of cholinergic systems |
12/21/1993 | US5272154 3,7 substituted indole and indazole compounds and pharmaceutical compositions containing them |
12/21/1993 | US5272153 Method of inhibiting the activity of leukocyte derived cytokines |
12/21/1993 | US5272151 Aminoacyl and oligopeptidyl derivatives of allopurinol exhibiting immunostimulatory activity, and pharmaceutical formulations containing these substances |
12/21/1993 | US5272149 Symptom controlled receptor substitution for addiction withdrawl |
12/21/1993 | US5272148 Heteroarenylpiperazines |
12/21/1993 | US5272147 Pyrazolopyrimidinone antianginal agents |
12/21/1993 | US5272145 (Quinolin-2-ylmethoxy)indoles as inhibitors of the biosynthesis of leukotrienes |
12/21/1993 | US5272144 Aryloxy-, arylthio-, heteroaryloxy-, heteroarylthio-alkenylene derivatives of amines and pharmaceutical use |
12/21/1993 | US5272143 6-oxoazepinoindole compounds, and pharmaceutical compositions containing them |
12/21/1993 | US5272141 Contraceptive and menstrual cycle controlling drug having oncostatic therapeutic properties for treatment of mammary tumors and melanomas, and method therefor |
12/21/1993 | US5272139 Amelioration or elimination of postoperative pain |
12/21/1993 | US5272138 Naturally occurring gangliosides containing de-N-acetyl-sialic acid and their applications as modifiers of cell physiology |
12/21/1993 | US5271946 Controlled release azelastine-containing pharmaceutical compositions |
12/21/1993 | US5271944 Pharmacologically enhanced formulations |
12/21/1993 | US5271942 Agent for reducing the growth of or removing the hair on the human body |
12/21/1993 | US5271941 Antisense oligonucleotides of human regulatory subunit RI.sub.α of cAMP-dependent protein kinases |
12/21/1993 | US5271939 Pharmaceutical compositions and methods of treatment to prevent and treat corneal scar formation produced by laser irradiation |
12/21/1993 | US5271930 Benzoate esters of polyalkoxylated block copolymers |